Bayer решил изменить приоритеты в разработке лекарств

Компания начнет уделять больше внимания онкологии, иммунологии и другим...
Copyright information of photo and video materials was taken from the website «Pharmaceutical messenger» , more details in our Terms of Service
Analysis
×
Bill Anderson
Last position: Member of Chamber of delegates (General Assembly of Commonwealth State of Virginia)
Bayer AG
Main activity:Chemical production